Seegene Stock Probability Of Bankruptcy
| 096530 Stock | KRW 25,100 500.00 1.95% |
Seegene |
Seegene Company chance of distress Analysis
Seegene's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Seegene Probability Of Bankruptcy | Less than 10% |
Most of Seegene's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seegene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Seegene probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Seegene odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Seegene financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Seegene has a Probability Of Bankruptcy of 10.0%. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all Republic of Korea stocks is notably lower than that of the firm.
Chance Of Distress
Low
High | Low |
Seegene has less than 10 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Seegene stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Seegene's odds of distress score SHOULD NOT be confused with the real chance of Seegene filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Seegene is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Seegene's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More InfoSeegene Fundamentals
| Return On Equity | 0.32 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 3.51 T | |||
| Shares Outstanding | 25.99 M | |||
| Shares Owned By Insiders | 30.90 % | |||
| Shares Owned By Institutions | 9.23 % | |||
| Price To Earning | 140.12 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 1.37 T | |||
| Gross Profit | 1 T | |||
| EBITDA | 415.89 B | |||
| Net Income | 536.56 B | |||
| Cash And Equivalents | 432.13 B | |||
| Total Debt | 102.81 B | |||
| Debt To Equity | 8.90 % | |||
| Current Ratio | 4.91 X | |||
| Cash Flow From Operations | 334.02 B | |||
| Target Price | 52050.0 | |||
| Number Of Employees | 1.01 K | |||
| Beta | -0.97 | |||
| Market Capitalization | 700.48 B | |||
| Total Asset | 1.49 T | |||
| Retained Earnings | 46.11 B | |||
| Working Capital | 139.97 B | |||
| Current Asset | 151.8 B | |||
| Current Liabilities | 11.83 B | |||
| Z Score | 3.6 | |||
| Annual Yield | 0 % | |||
| Net Asset | 1.49 T |
About Seegene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Seegene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seegene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seegene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Seegene Stock
Seegene financial ratios help investors to determine whether Seegene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seegene with respect to the benefits of owning Seegene security.